Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Berchuck

Showing results (481-490 of 683) with videos related to

Pageof 69
Sort By:
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 18, 2019
Prevalence of pathogenic germline cancer risk variants in high-risk urothelial carcinomaAmin H Nassar, Sarah Abou Alaiwi, Saud H AlDubayan, et al.
Gynecologic Oncology|March 16, 2016
The influence of clinical and genetic factors on patient outcome in small cell carcinoma of the ovary, hypercalcemic typeLeora Witkowski, Catherine Goudie, Pilar Ramos, et al.
Cancer|February 11, 2026
Evolving strategies in prostate cancer: Emerging approaches and unmet needs from the Bridging the Gaps in Prostate Cancer expert panelRana R McKay, Benjamin L Maughan, Alicia K Morgans, et al.
Twin Research and Human Genetics : the Official Journal of the International Society for Twin Studies|February 18, 2010
Variation at 8q24 and 9p24 and risk of epithelial ovarian cancerKristin L White, Thomas A Sellers, Brooke L Fridley, et al.
Cancer Cell|October 6, 2009
Proteomic and genetic approaches identify Syk as an AML targetCynthia K Hahn, Jacob E Berchuck, Kenneth N Ross, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2026
ctDNA dynamics and recurrence patterns after organ-sparing trimodality therapy for bladder cancerIlana B Epstein, Adetolani Odogiyon, Stephanie Berg, et al.
Cancer Research|August 18, 2004
Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancerZhen Zhang, Robert C Bast, Yinhua Yu, et al.
Gynecologic Oncology|April 5, 2011
Proteomic analysis of stage I endometrial cancer tissue: identification of proteins associated with oxidative processes and inflammationG Larry Maxwell, Brian L Hood, Roger Day, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 28, 2015
Population distribution of lifetime risk of ovarian cancer in the United StatesCeleste Leigh Pearce, Daniel O Stram, Roberta B Ness, et al.
JAMA Network Open|February 24, 2023
Association of Frequent Aspirin Use With Ovarian Cancer Risk According to Genetic SusceptibilityLauren M Hurwitz, Penelope M Webb, Susan J Jordan, et al.
Pageof 69

Showing results (481-490 of 683) with videos related to

Sort By:
Pageof 69
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 18, 2019
Prevalence of pathogenic germline cancer risk variants in high-risk urothelial carcinomaAmin H Nassar, Sarah Abou Alaiwi, Saud H AlDubayan, et al.
Gynecologic Oncology|March 16, 2016
The influence of clinical and genetic factors on patient outcome in small cell carcinoma of the ovary, hypercalcemic typeLeora Witkowski, Catherine Goudie, Pilar Ramos, et al.
Cancer|February 11, 2026
Evolving strategies in prostate cancer: Emerging approaches and unmet needs from the Bridging the Gaps in Prostate Cancer expert panelRana R McKay, Benjamin L Maughan, Alicia K Morgans, et al.
Twin Research and Human Genetics : the Official Journal of the International Society for Twin Studies|February 18, 2010
Variation at 8q24 and 9p24 and risk of epithelial ovarian cancerKristin L White, Thomas A Sellers, Brooke L Fridley, et al.
Cancer Cell|October 6, 2009
Proteomic and genetic approaches identify Syk as an AML targetCynthia K Hahn, Jacob E Berchuck, Kenneth N Ross, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2026
ctDNA dynamics and recurrence patterns after organ-sparing trimodality therapy for bladder cancerIlana B Epstein, Adetolani Odogiyon, Stephanie Berg, et al.
Cancer Research|August 18, 2004
Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancerZhen Zhang, Robert C Bast, Yinhua Yu, et al.
Gynecologic Oncology|April 5, 2011
Proteomic analysis of stage I endometrial cancer tissue: identification of proteins associated with oxidative processes and inflammationG Larry Maxwell, Brian L Hood, Roger Day, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 28, 2015
Population distribution of lifetime risk of ovarian cancer in the United StatesCeleste Leigh Pearce, Daniel O Stram, Roberta B Ness, et al.
JAMA Network Open|February 24, 2023
Association of Frequent Aspirin Use With Ovarian Cancer Risk According to Genetic SusceptibilityLauren M Hurwitz, Penelope M Webb, Susan J Jordan, et al.
Pageof 69